loading page

Deep phenotyping and whole-exome sequencing improved the diagnosis yield for nuclear pedigrees with neurodevelopmental disorders
  • +4
  • Qingqing Wang,
  • Xia Tang,
  • ke yang,
  • Xiaodong Huo,
  • Hui Zhang,
  • Keyue Ding,
  • Shixiu Liao
Qingqing Wang
Henan Provincial People’s Hospital

Corresponding Author:[email protected]

Author Profile
Xia Tang
Henan Provincial People’s Hospital
Author Profile
ke yang
Henan Provincial People's Hospital
Author Profile
Xiaodong Huo
Henan Provincial People’s Hospital
Author Profile
Hui Zhang
Henan Provincial People’s Hospital
Author Profile
Keyue Ding
Henan Provincial People’s Hospital
Author Profile
Shixiu Liao
Henan Provincial People’s Hospital
Author Profile

Abstract

Neurodevelopmental disorders, a group of early-onset neurological disorders with significantly clinical and genetic heterogeneity, remain a diagnostic odyssey for clinical genetic evaluation. In a total of 45 parent-child trios/quads with these disorders that was ‘not yet diagnosed’ by the traditional testing methods, we assessed the diagnostic yield by the combined use of standardized phenotypes and whole-exome sequencing data. Using a standardized vocabulary of phenotypic abnormalities from Human Phenotype Ontology (HPO), we performed deep phenotyping for these pedigrees to characterize multiple clinical features that was extracted from Chinese electronic medical records (EMRs). By matching HPO terms with known human diseases or cross-species comparison, together with whole-exome sequencing data, we prioritized candidate mutations/genes that underlies these pedigrees. We obtained a diagnostic yield of 49% (22 out of 45) with probably or possibly genetic diagnosis, of which the compound heterozygosity and de novo mutations accounted for the half of the diagnosis. Of note, the pedigrees with probable or possible diagnosis accompanied with a greater number of phenotypes implicated in non-nervous systems. The combined use of deep phenotyping and whole-exome sequencing provide implications for etiological evaluation for neurodevelopmental disorders in the clinical setting.